Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Laboratory Corp American Holdings
(NY:
LH
)
258.84
-1.56 (-0.60%)
Streaming Delayed Price
Updated: 10:07 AM EST, Jan 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Laboratory Corp American Holdings
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses
March 26, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting...
Via
StockStory
3 Healthcare Stocks Walking a Fine Line
March 18, 2025
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...
Via
StockStory
Topics
Stocks
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
March 14, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Quest (NYSE:DGX) and the best and worst...
Via
StockStory
3 Reasons to Avoid LH and 1 Stock to Buy Instead
March 06, 2025
Over the past six months, Labcorp has been a great trade, beating the S&P 500 by 6.9%. Its stock price has climbed to $255.01, representing a healthy 13.9% increase. This was partly thanks to its solid...
Via
StockStory
Topics
Stocks
What 10 Analyst Ratings Have To Say About Labcorp Hldgs
↗
March 04, 2025
Via
Benzinga
Is the Market Bullish or Bearish on Labcorp Hldgs?
↗
February 28, 2025
Via
Benzinga
Labcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment Mixed
↗
March 05, 2025
The research firm noted that post-pandemic utilization rates have remained high, and Labcorp is positioned to capitalize on this trend through its core diagnostics business.
Via
Stocktwits
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect
February 17, 2025
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting results tomorrow morning. Here’s what to look for.
Via
StockStory
Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook
↗
February 06, 2025
Labcorp's Q4 EPS of $3.45 topped estimates, with sales rising 9.8% to $3.33 billion. 2025 guidance points to continued growth in diagnostics and biopharma.
Via
Benzinga
Labcorp (NYSE:LH) Surprises With Q4 Sales, Full-Year Outlook Slightly Exceeds Expectations
February 06, 2025
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.8% year on year to $3.33 billion. The company’s full-year revenue...
Via
StockStory
Earnings Scheduled For February 6, 2025
↗
February 06, 2025
Via
Benzinga
Beyond The Numbers: 6 Analysts Discuss Labcorp Holdings Stock
↗
February 03, 2025
Via
Benzinga
Beyond The Numbers: 8 Analysts Discuss Labcorp Holdings Stock
↗
January 07, 2025
Via
Benzinga
Analyst Expectations For Labcorp Holdings's Future
↗
December 10, 2024
Via
Benzinga
Labcorp (LH) Reports Earnings Tomorrow: What To Expect
February 05, 2025
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings tomorrow before the bell. Here’s what to look for.
Via
StockStory
Jim Cramer Says Lazard Is 'Really Inexpensive,' Recommends Buying This Tech Stock
↗
January 03, 2025
Via
Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
↗
November 09, 2024
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.
Via
Benzinga
Topics
Government
Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience
November 04, 2024
From
Praia Health
Via
Business Wire
Expert Outlook: Labcorp Holdings Through The Eyes Of 12 Analysts
↗
October 25, 2024
Via
Benzinga
Analyst Ratings For Labcorp Holdings
↗
September 20, 2024
Via
Benzinga
Analyst Expectations For Labcorp Holdings's Future
↗
August 05, 2024
Via
Benzinga
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
↗
October 24, 2024
LabCorp Q3 2024 EPS beats expectations at $3.50, with 7.4% revenue growth to $3.28B. Adjusted EPS guidance revised due to weather.
Via
Benzinga
Topics
Earnings
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
↗
October 24, 2024
Via
Benzinga
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
October 16, 2024
From
NOWDiagnostics, Inc.
Via
Business Wire
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
↗
August 02, 2024
Via
Benzinga
Labcorp Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
↗
July 08, 2024
Via
Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
↗
August 26, 2024
Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing...
Via
Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
↗
August 04, 2024
Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H....
Via
Benzinga
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
↗
August 01, 2024
LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, driven by organic revenue growth and acquisitions. LabCorp revised its 2024...
Via
Benzinga
Is This Telehealth Stock a Buy After the Recent Pullback?
July 19, 2024
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.
Via
MarketBeat
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
